Role of nuclear receptor coregulators in metabolism

References

• Haslam DW, James WP. Obesity. Lancet366(9492), 1197–1209 (2005).
   PubMed Web of Science ®Google Scholar
• Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet366(9491), 1059–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Seidell JC. Obesity as a health problem. In: Oxford Textbook of Endocrinology and DIabetes. Wass JAH, Shalet SM (Eds). Oxford University Press, Oxford, UK 1611–1614 (2002).
   Google Scholar
• van Harmelen V, Skurk T, Rohrig K et al. Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int. J. Obes. Relat. Metab. Disord.27(8), 889–895 (2003).
   PubMed Web of Science ®Google Scholar
• Baron AD, Brechtel G, Wallace P, Edelman SV. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am. J. Physiol. Endocrinol. Metab.255(6), E769–E774 (1988).
   PubMed Web of Science ®Google Scholar
• Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin. Endocrinol. (Oxford)64(4), 355–365 (2006).
   PubMed Web of Science ®Google Scholar
• Robinson-Rechavi M, Garcia HE, Laudet V. The nuclear receptor superfamily. J. Cell. Sci.116(4), 585–586 (2003).
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: the second decade. Cell83(6), 835–839 (1995).
   PubMed Web of Science ®Google Scholar
• Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol.65, 261–311 (2003).
   PubMed Web of Science ®Google Scholar
• Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology137(1), 354–366 (1996).
   PubMed Web of Science ®Google Scholar
• Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl Acad. Sci. USA91(23), 11012–11016 (1994).
   PubMed Web of Science ®Google Scholar
• Fürnsinn C, Willson T, Brunmair B. Peroxisome proliferator-activated receptor-+Ý, a regulator of oxidative capacity, fuel switching and cholesterol transport. Diabetologia50(1), 8–17 (2007).
   PubMed Web of Science ®Google Scholar
• Wang YX, Lee CH, Tiep S et al. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell113(2), 159–170 (2003).
   PubMed Web of Science ®Google Scholar
• Rosen ED, Sarraf P, Troy AE et al. PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell4(4), 611–617 (1999).
   PubMed Web of Science ®Google Scholar
• Sprecher DL, Massien C, Pearce G et al. Triglyceride: high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist. Arterioscler. Thromb. Vasc. Biol.27(2), 359–365 (2007).
   PubMed Web of Science ®Google Scholar
• Giguere V. To ERR in the estrogen pathway. Trends Endocrinol. Metab.13(5), 220–225 (2002).
   Google Scholar
• Huss JM, Torra IP, Staels B, Giguere V, Kelly DP. Estrogen-related receptor α directs peroxisome proliferator-activated receptor α signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol.24(20), 9079–9091 (2004).
   PubMed Web of Science ®Google Scholar
• Villena JA, Hock MB, Chang WY et al. Orphan nuclear receptor estrogen-related receptor α is essential for adaptive thermogenesis. Proc. Natl Acad. Sci. USA104(4), 1418–1423 (2007).
   PubMed Web of Science ®Google Scholar
• Kallen J, Schlaeppi J-M, Bitsch F et al. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα): crystal structure of ERRα ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1α. J. Biol. Chem.279(47), 49330–49337 (2004).
   PubMed Web of Science ®Google Scholar
• Willy PJ, Murray IR, Qian J et al. Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand. Proc. Natl Acad. Sci. USA101(24), 8912–8917 (2004).
   PubMed Web of Science ®Google Scholar
• McKenna NJ, O’Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell108(4), 465–474 (2002).
   PubMed Web of Science ®Google Scholar
• Puigserver P, Wu Z, Park CW et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell92(6), 829–839 (1998).
   PubMed Web of Science ®Google Scholar
• Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β ), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem.277(3), 1645–1648 (2002).
   PubMed Web of Science ®Google Scholar
• Andersson U, Scarpulla RC. PGC-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol. Cell. Biol.21(11), 3738–3749 (2001).
   PubMed Web of Science ®Google Scholar
• Cavailles V, Dauvois S, L’Horset F et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J.14(15), 3741–3751 (1995).
   PubMed Web of Science ®Google Scholar
• L’Horset F, Dauvois S, Heery D, Cavailles V, Parker M. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol. Cell. Biol.16(11), 6029–6036 (1996).
   PubMed Web of Science ®Google Scholar
• Heery DM, Hoare S, Hussain S, Parker MG, Sheppard H. Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J. Biol. Chem.276(9), 6695–6702 (2001).
   PubMed Web of Science ®Google Scholar
• Hu X, Chen Y, Farooqui M et al. Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation. J. Biol. Chem.279(1), 319–325 (2004).
   Google Scholar
• Christian M, Tullet JM, Parker MG. Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. J. Biol. Chem.279(15), 15645–15651 (2004).
   PubMedGoogle Scholar
• Puigserver P, Adelmant G, Wu Z et al. Activation of PPAR coactivator-1 through transcription factor docking. Science286(5443), 1368–1371 (1999).
   PubMed Web of Science ®Google Scholar
• Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev.84(1), 277–359 (2004).
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab.293(2), E444–E452 (2007).
   PubMed Web of Science ®Google Scholar
• Bogacka I, Xie H, Bray GA, Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes54(5), 1392–1399 (2005).
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Petrovic N, Lindgren EM, Jacobsson A, Cannon B. PPARγ in the control of brown adipocyte differentiation. Biochim. Biophys. Acta1740(2), 293–304 (2005).
   PubMed Web of Science ®Google Scholar
• Sears IB, MacGinnitie MA, Kovacs LG, Graves RA. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor γ. Mol. Cell. Biol.16(7), 3410–3419 (1996).
   PubMed Web of Science ®Google Scholar
• Tiraby C, Tavernier G, Lefort C et al. Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem.278(35), 33370–33376 (2003).
   PubMed Web of Science ®Google Scholar
• Uldry M, Yang W, St-Pierre J et al. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab.3(5), 333–341 (2006).
   PubMed Web of Science ®Google Scholar
• Leone TC, Lehman JJ, Finck BN et al. PGC-1&α; deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol.3(4), e101 (2005).
   PubMed Web of Science ®Google Scholar
• Lin J, Wu PH, Tarr PT et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell119(1), 121–135 (2004).
   PubMed Web of Science ®Google Scholar
• del Mar Gonzalez-Barroso M, Pecqueur C, Gelly C et al. Transcriptional activation of the human UCP1 gene in a rodent cell line. synergism of retinoids, isoproterenol, and thiozolidinedione is mediated by a multipartite response element. J. Biol. Chem.275(41), 31722–31732 (2000).
   PubMedGoogle Scholar
• Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1α (PGC-1α ) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and -γ . Identification of novel leucine-rich interaction motif within PGC-1α. J. Biol. Chem.277(43), 40265–40274 (2002).
   PubMed Web of Science ®Google Scholar
• Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα ). J. Biol. Chem.278(11), 9013–9018 (2003).
   PubMed Web of Science ®Google Scholar
• Lelliott CJ, Medina-Gomez G, Petrovic N et al. Ablation of PGC-1&β; results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol.4(11), e369 (2006).
   PubMedGoogle Scholar
• Leonardsson G, Steel JH, Christian M et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc. Natl Acad. Sci. USA101(22), 8437–8442 (2004).
   PubMed Web of Science ®Google Scholar
• Christian M, Kiskinis E, Debevec D et al. RIP140-targeted repression of gene expression in adipocytes. Mol. Cell. Biol.25(21), 9383–9391 (2005).
   PubMed Web of Science ®Google Scholar
• Powelka AM, Seth A, Virbasius JV et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J. Clin. Invest.116(1), 125–136 (2006).
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N. Engl. J. Med.350(7), 664–671 (2004).
   PubMed Web of Science ®Google Scholar
• Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem.75(1), 19–37 (2006).
   PubMed Web of Science ®Google Scholar
• Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev.76(2), 371–423 (1996).
   PubMed Web of Science ®Google Scholar
• Larsson L, Edstrom L, Lindegren B, Gorza L, Schiaffino S. MHC composition and enzyme-histochemical and physiological properties of a novel fast-twitch motor unit type. Am. J. Physiol. Cell Physiol.261(1), C93–C101 (1991).
   PubMedGoogle Scholar
• Wang Y-X, Zhang C-L, Yu RT et al. Regulation of muscle fiber type and running endurance by PPAR&δ. PLoS Biol.2(10), e294 (2004).
   PubMed Web of Science ®Google Scholar
• Lin J, Wu H, Tarr PT et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature418(6899), 797–801 (2002).
   PubMed Web of Science ®Google Scholar
• Baar KEIT, Wende AR, Jones TE et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J.16(14), 1879–1886 (2002).
   PubMed Web of Science ®Google Scholar
• Arany Z, Lebrasseur N, Morris C et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab.5(1), 35–46 (2007).
   PubMed Web of Science ®Google Scholar
• Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA100(14), 8466–8471 (2003).
   PubMed Web of Science ®Google Scholar
• Russell AP, Feilchenfeldt J, Schreiber S et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes52(12), 2874–2881 (2003).
   PubMed Web of Science ®Google Scholar
• Kramer DK, Ahlsen M, Norrbom J et al. Human skeletal muscle fibre type variations correlate with PPAR α, PPAR δ and PGC-1 α mRNA. Acta Physiol. (Oxford)188(3–4), 207–216 (2006).
   PubMed Web of Science ®Google Scholar
• Seth A, Steel JH, Nichol D et al. The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab.6(3), 236–245 (2007).
   PubMed Web of Science ®Google Scholar
• St-Pierre J, Drori S, Uldry M et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell127(2), 397–408 (2006).
   PubMed Web of Science ®Google Scholar
• Weydt P, Pineda VV, Torrence AE et al. Thermoregulatory and metabolic defects in Huntington’s disease transgenic mice implicate PGC-1α in Huntington’s disease neurodegeneration. Cell Metab.4(5), 349–362 (2006).
   PubMed Web of Science ®Google Scholar
• Vianna CR, Huntgeburth M, Coppari R et al. Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance. Cell Metab.4(6), 453–464 (2006).
   PubMed Web of Science ®Google Scholar
• Sladek R, Bader JA, Giguere V. The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol. Cell. Biol.17(9), 5400–5409 (1997).
   PubMed Web of Science ®Google Scholar
• Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab.1(6), 361–370 (2005).
   PubMed Web of Science ®Google Scholar
• Puigserver P, Rhee J, Lin J et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1. Mol. Cell8(5), 971–982 (2001).
   PubMed Web of Science ®Google Scholar
• Cao W, Daniel KW, Robidoux J et al. p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Mol. Cell. Biol.24(7), 3057–3067 (2004).
   PubMed Web of Science ®Google Scholar
• Christian M, White R, Parker MG. Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol. Metab.17(6), 243–250 (2006).
   PubMed Web of Science ®Google Scholar
• Han SH, Quon MJ, Koh KK. Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-α activators. Hypertension46(5), 1086–1092 (2005).
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med.351(11), 1106–1118 (2004).
   PubMed Web of Science ®Google Scholar
• Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med.356(24), 2457–2471 (2007).
   PubMed Web of Science ®Google Scholar
• Debevec D, Christian M, Morganstein D et al. Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor α. Mol. Endocrinol.21(7), 1581–1592 (2007).
   PubMed Web of Science ®Google Scholar
• Fievet C, Fruchart J-C, Staels B. PPARα and PPARγ dual agonists for the treatment of Type 2 diabetes and the metabolic syndrome. Curr. Opin. Pharmacol.6(6), 606–614 (2006).
   PubMed Web of Science ®Google Scholar
• Kendall DM, Rubin CJ, Mohideen P et al. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (α/γ) peroxisome proliferator-activated receptor activator, in patients with Type 2 diabetes inadequately controlled with metformin monotherapy: a double-blind, randomized, pioglitazone-comparative study. Diabetes Care29(5), 1016–1023 (2006).
   PubMed Web of Science ®Google Scholar
• Nissen SE, Wolski K, Topol EJ. Effect of Muraglitazar on death and major adverse cardiovascular events in patients with Type 2 diabetes mellitus. JAMA294(20), 2581–2586 (2005).
   PubMed Web of Science ®Google Scholar
• Seth A, Steel JH, Nichol D et al. The transcriptional co-repressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab.6(3), 236–245 (2007).
   PubMed Web of Science ®Google Scholar
• Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP. PGC-1α coactivates PDK4 gene expression via the orphan nuclear receptor ERRα: a mechanism for transcriptional control of muscle glucose metabolism. Mol. Cell. Biol.25(24), 10684–10694 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ma K, Sadana P et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J. Biol. Chem.281(52), 39897–39906 (2006).
   PubMed Web of Science ®Google Scholar
• Mazzucotelli A, Viguerie N, Tiraby C et al. The transcriptional coactivator PGC-1α and the nuclear receptor PPARα control the expression of glycerol kinase and metabolism genes independently of PPARγ activation in human white adipocytes. Diabetes56(10), 2467–2475 (2007).
   Google Scholar
• Koves TR, Li P, An J et al. Peroxisome proliferator-activated receptor-g co-activator 1a-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem.280(39), 33588–33598 (2005).
   PubMed Web of Science ®Google Scholar